ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInSponsored Education from ACCC Corporate PartnersACCC eLearning LogInPresentations & Abstracts
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
5425 Wisconsin Ave #600, Chevy Chase, MD 20815
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

CMS Interim Final Rule 2 COVID-19 Response: Telehealth

May 8, 2020

CMS Interim Final Rule 2 COVID-19 Response: Telehealth

By Teri Bedard, BA, RT(R)(T), CPC

On April 30, 2020, the Centers for Medicare and Medicaid Services (CMS) issued a second Interim Final Rule in response to the COVID-19 pandemic. This ruling adds to and changes many of the recent expansions and waivers of the provisions previously outlined by CMS since the Public Health Emergency (PHE) was initiated.

The CMS Interim Final Rule 2 is located in its entirety online. Below is a summary of the finalized changes as they apply to the provision of telehealth. Note that due to the rapidly changing response to the PHE, modifications could be released by CMS that may impact or change regulations contained within this summary.

Telehealth Expansion Update

In response to stakeholder feedback to CMS related to the initial Interim Final Rule released on March 30, 2020, CMS has made additional adjustments to telehealth and telehealth services available during the public health emergency (PHE). Stakeholders noted they are predominantly providing evaluation and management (E/M) services by telephone only. This is due to very few Medicare beneficiaries having the technology to do a visit with video capabilities or refusing to participate in a visit with video capabilities.

The use of telephone visits is replacing care that CMS would otherwise expect to be in-person or by the defined telehealth visit requiring audio-video capability. Due to this, CMS indicated the audio-only or telephone E/M visits should be considered telehealth visits and added them to the list of Medicare telehealth services for the duration of the PHE. CMS also noted the use of billing or telephone visits are only to be used for medical discussions. They are not to be used for administrative or other non-medical discussions with the patient. In addition, these visits still have cost-sharing obligations, meaning there may be a copay for the patient for each visit depending upon payer guidelines.

To account for the application of the telephone or audio-only visits, CMS has adjusted the Relative Value Units (RVUs) assigned to CPT® codes 99441-99443. Codes 98966-98968 are used by practitioners who cannot independently bill for E/M visits. These codes are not used in place of the outpatient office visits, so the RVUs assigned by CMS have not been adjusted.

The updated RVU values crosswalk from the established values for codes 99212-99214 for both Work and Direct Practice Expense. The values for Direct Practice Expense will crosswalk as follows: 99212 to 99441, 99213 to 99442, and 99214 to 99443. The values of Work RVUs for the duration of the PHE for the audio-only codes are as follows: 99441 = 0.48, 99442 = 0.97, and 99443 = 1.50.

CMS also indicated in the Interim Final Rule 2 that they would be adjusting how codes are added to the telehealth list in response to the PHE. CMS stated they believe the table, as adjusted over the last two interim final rules, reflects the majority of services that would be appropriate to bill for services provided to Medicare beneficiaries during the PHE. There may be other services over the duration of the PHE which may need to be added related to infection control, patient safety, and other public health concerns. In the event new services need to be added, CMS is implementing a new practice that does not involve notice and comment rulemaking. Instead, a sub-regulatory process to modify the list of telehealth services will be conducted.

CMS has published a list of services payable under the Medicare Physician Fee Schedule when furnished via telehealth. It is important to note that there are only a handful of codes that are considered telehealth that can be provided by audio-only.

Using Time to Select Appropriate Level of Telehealth Visit

Stakeholders submitted comments to CMS regarding the ability to use time as the basis for outpatient office E/M visits as part of the initial Interim Final Rule. CMS indicated in the initial ruling that the times, as identified in the CMS public use files, were the values to use; however, the values are not the same as those in the CPT® definitions for codes 99201-99215. CMS agreed these discrepancies can be confusing. CMS is implementing, for the duration of the PHE, the use of the typical times associated with the levels of the outpatient office E/M codes as established as part of the CPT® definition.

CMS is also clarifying, per the initial Interim Final Rule, when using time for the selection of the appropriate level of visit, the time is defined as all of the time associated with the E/M on the day of the encounter. All of the requirements for documenting the history and physical exam in the medical record do not apply for establishing the level of a telehealth provided visit.

Technical Charges for Hospitals Related to Telehealth Services

As part of this second Interim Final Rule, when a patient is in the hospital outpatient department and the physician is at a distant site, not somewhere else in the hospital, there may be a technical charge billable by the hospital. Since the hospital is using resources for the patient to access the real-time audio-video technology, the room, and staff resources, there are expenses to be accounted for by the hospital.

In these scenarios, a telehealth originating site facility fee would be paid by CMS to the hospital just as it would under telehealth services prior to the PHE. As part of the waiver, this is extended to the patient’s home as an originator site as well. Hospitals are reminded that services should only be provided to the patient in their home after the patient’s home is designated as PBD to the hospital for the provision of services. This would make the home an originator site and the location relative to the physician at a distant site, which is not in the hospital. Documentation of the service and location of the patient and physician are needed to support the telehealth visit provided.

Comments to Second Interim Final Rule

CMS is moving forward without delay the implementation of the finalized provisions in the second Interim Final Rule. The rules as outlined are retroactive to March 1, 2020. CMS is providing a 60-day public comment period that can be accessed at http://www.regulations.gov.

Additional Links to CMS Transmittals and Resources

There are several transmittals by CMS that also summarize and provide additional information for providers. The following links will take stakeholders directly to these transmittals:

  • Coronavirus Waivers & Flexibilities
  • COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers
  • Physicians and Other Clinicians: CMS Flexibilities to Fight COVID-19
  • Hospitals: CMS Flexibilities to Fight COVID-19
  • List of Telehealth Services

Teri Bedard, BA, RT(R)(T), CPC is the Director of Client Services at Revenue Cycle Coding Strategies LLC. In a previous blog post, Bedard answered questions about the details of the first CMS Interim Final Rule as it applies to the coverage of telehealth during the COVID-19 public health emergency. An archived webinar featuring Bedard further addresses the implications of the temporary CMS telehealth coverage decisions in response to the pandemic.

For resources on COVID-19 as it applies to the oncology community, visit ACCC’s continually updated Coronavirus Responsepage. ACCC members can also access ACCCExchange, a forum that allows them to communicate in real time with their colleagues about how the COVID-19 virus is affecting their communities and their patients.

Related Content

Highlights From Volume 41, Number 4 Oncology IssuesACCCBuzz Blog

Highlights From Volume 41, Number 4 Oncology Issues

Gabrielle Stearns

August 20, 2026

Transforming Access to Care Through Pre-Intake NavigationACCCBuzz Blog

Transforming Access to Care Through Pre-Intake Navigation

Rachel Radwan

August 6, 2026

An APP-Led Outpatient Bispecific Antibody Clinic

Upcoming Events

ACCC 43rd National Oncology Conference

ACCC 43rd National Oncology Conference

In Person October 21, 2026 at 8:00 AM EDT450 Summer St, Boston, MA 02210, USAOmni Boston Hotel at the Seaport, Boston
Register Now!
ACCC Oncology Reimbursement Meeting | Reno

ACCC Oncology Reimbursement Meeting | Reno

In Person November 4, 2026 at 8:00 AM EST255 North Virginia Street, Reno, NV, USAWhitney Peak Hotel Reno, Tapestry Collection by Hilton,
Register Now!
ACCC Oncology Reimbursement Meeting | Providence

ACCC Oncology Reimbursement Meeting | Providence

In Person November 10, 2026 at 8:00 AM EST5 Avenue of the Arts, Providence, RI, USARenaissance Providence Downtown Hotel,
Register Now!
NMSCO 2026 Fall Conference
Oncology

NMSCO 2026 Fall Conference

In Person Conference & ConventionSeptember 12, 2026 at 7:30 AM MDT2101 Louisiana Boulevard NE Albuquerque, NM, 87110Marriott Albuquerque, Albuquerque
Register Now!
TxSCO 2026 Annual Conference
Oncology

TxSCO 2026 Annual Conference

In Person Conference & ConventionSeptember 18, 2026 at 6:00 PM CDT501 Gaylord Trail, Grapevine, TX, USAGaylord Texan Resort & Convention Center, Grapevine
Register Now!
KYSCO 2026 Fall Oncology Review
Oncology

KYSCO 2026 Fall Oncology Review

In Person Conference & ConventionSeptember 19, 2026 at 7:00 AM EDT500 S 4th St, Louisville, KY, USAThe Seelbach Hilton Louisville, Louisville
Register Now!
ESHOS Horizons 2026
Oncology

ESHOS Horizons 2026

In Person Conference & ConventionSeptember 19, 2026 at 7:30 AM EDT1 Liberty Street, New York, NY, USAConvene at One Liberty Plaza, New York
Register Now!
MSOS 2026 Bozeman Meeting
Oncology

MSOS 2026 Bozeman Meeting

In Person Meeting & NetworkingSeptember 22, 2026 at 5:30 PM EDT5 W Mendenhall St suite 102, Bozeman, MT 59715, USA Urban Kitchen, Bozeman
Register Now!
MSCO 2026 Fall Conference
Oncology

MSCO 2026 Fall Conference

In Person Conference & ConventionSeptember 22, 2026 at 5:00 PM CDT1500 Park Pl Blvd, Minneapolis, MN, USADoubleTree by Hilton Hotel Minneapolis - Park Place, Minneapolis
Register Now!
HSCO 2026 September Dinner Symposium
Oncology

HSCO 2026 September Dinner Symposium

In Person Conference & ConventionSeptember 23, 2026 at 5:30 PM HST3660 Waialae Ave, Honolulu, HI, USA3660 On The Rise, Honolulu
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Highlights From Volume 41, Number 4 Oncology Issues

Highlights From Volume 41, Number 4 Oncology Issues

From precision medicine to psychosocial care to navigation for a diverse population, the latest issue Oncology Issues brings insights into not just institutional and administrative barriers to treatment, but areas of care that directly impact the lived experience of those navigating the cancer care continuum.

Transforming Access to Care Through Pre-Intake Navigation

Transforming Access to Care Through Pre-Intake Navigation

The University of Texas MD Anderson Cancer Center in Houston, Texas, developed a novel Pre-Intake Navigation (PIN) program, which identifies and resolves early financial and insurance barriers, enabling patients to access timely, high-quality cancer care with less anxiety and fewer delays. PIN shifts financial navigation from a late-stage, reactive task to an early, standardized, patient‑centered process embedded in the call center workflow.

ACCCBuzz Blog

An APP-Led Outpatient Bispecific Antibody Clinic

Rachel Radwan

August 4, 2026

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual MeetingACCCBuzz Blog

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual Meeting

Rachel Radwan

July 29, 2026

Designing a Safe, Fully Outpatient CAR T-Cell Program in the CommunityACCCBuzz Blog

Designing a Safe, Fully Outpatient CAR T-Cell Program in the Community

Rachel Radwan

July 27, 2026

Local Staff, Lasting Impact: A New Model for Rural Cancer PreventionACCCBuzz Blog

Local Staff, Lasting Impact: A New Model for Rural Cancer Prevention

Rachel Radwan

July 16, 2026

A Pharmacist-Led Strategy to Improve Care With Oncolytic Virus TreatmentsACCCBuzz Blog

A Pharmacist-Led Strategy to Improve Care With Oncolytic Virus Treatments

Rachel Radwan

July 14, 2026

Extending Patient-Centered Cancer Care to Transgender and Nonbinary IndividualsACCCBuzz Blog

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

Gabrielle Stearns

June 30, 2026

An APP-Led Outpatient Bispecific Antibody Clinic

An APP-Led Outpatient Bispecific Antibody Clinic

Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual Meeting

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual Meeting

At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Closing the Gap in Medical Necessity Review With a Clinical Documentation Integrity Registered Nurse - [Mini Podcast] Ep. 239

Utilizing APPs to Deliver Bispecific Antibodies in the Outpatient Setting - [Mini Podcast] Ep. 238

Between the Orders and the Infusion: The Patient Experience of Bispecific Antibodies - [Podcast] Ep. 237

Centering Compassion in Cancer Care – [Video Podcast] Ep. 64

View All Podcasts

Latest from Oncology Issues

August 2026
August 2026
June 2026
April 2026
February 2026
December 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login